Journal
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 488, Issue 2, Pages 130-139Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2009.06.019
Keywords
Dopa decarboxylase; Pyridoxal 5 '-phosphate; Oxidase activity; Pyridoxal-lysine
Categories
Funding
- Italian Ministero dell'Universita e della Ricerca
- University of Verona
Ask authors/readers for more resources
The pyridoxal 5'-phosphate dependent-enzyme Dopa decarboxylase, responsible for the irreversible conversion of L-Dopa to dopamine, is an attractive drug target. The contribution of the pyridoxal-Lys303 to the catalytic mechanisms of decarboxylation and oxidative deamination is analyzed. The K303A variant binds the coenzyme with a 100-fold decreased apparent equilibrium binding affinity with respect to the wild-type enzyme. Unlike the wild-type, K303A in the presence of L-Dopa displays a parallel progress course of formation of both dopamine and 3,4-dihydroxyphenylacetaldehyde (plus ammonia) with a burst followed by a linear phase. Moreover, the finding that the catalytic efficiencies of decarboxylation and of oxidative deamination display a decrease of 1500- and 17-fold, respectively, with respect to the wild-type, is indicative of a different impact of Lys303 mutation on these reactions. Kinetic analyses reveal that Lys303 is involved in external aldimine formation and hydrolysis as well as in product release which affects the rate-determining step of decarboxylation. (C) 2009 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available